These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37269324)

  • 1. The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update.
    Matera MG; Rogliani P; Novelli G; Cazzola M
    Expert Opin Drug Metab Toxicol; 2023; 19(5):285-295. PubMed ID: 37269324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to β2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease.
    Konno S; Makita H; Hasegawa M; Nasuhara Y; Nagai K; Betsuyaku T; Hizawa N; Nishimura M
    Pharmacogenet Genomics; 2011 Nov; 21(11):687-93. PubMed ID: 21881540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do genetic polymorphisms alter patient response to inhaled bronchodilators?
    Lima JJ
    Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1231-40. PubMed ID: 25102170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of Bronchodilator Response: Future Directions.
    Sordillo JE; Kelly RS; Lutz SM; Lasky-Su J; Wu AC
    Curr Allergy Asthma Rep; 2021 Dec; 21(12):47. PubMed ID: 34958416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
    Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP
    Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
    Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
    Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of
    Scaparrotta A; Franzago M; Marcovecchio ML; Di Pillo S; Chiarelli F; Mohn A; Stuppia L
    J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):164-173. PubMed ID: 30855197
    [No Abstract]   [Full Text] [Related]  

  • 8. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts.
    Litonjua AA; Lasky-Su J; Schneiter K; Tantisira KG; Lazarus R; Klanderman B; Lima JJ; Irvin CG; Peters SP; Hanrahan JP; Liggett SB; Hawkins GA; Meyers DA; Bleecker ER; Lange C; Weiss ST
    Am J Respir Crit Care Med; 2008 Oct; 178(7):688-94. PubMed ID: 18617639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association analysis of COPD candidate genes with bronchodilator responsiveness.
    Kim WJ; Hersh CP; DeMeo DL; Reilly JJ; Silverman EK
    Respir Med; 2009 Apr; 103(4):552-7. PubMed ID: 19111454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma.
    Mak ACY; White MJ; Eckalbar WL; Szpiech ZA; Oh SS; Pino-Yanes M; Hu D; Goddard P; Huntsman S; Galanter J; Wu AC; Himes BE; Germer S; Vogel JM; Bunting KL; Eng C; Salazar S; Keys KL; Liberto J; Nuckton TJ; Nguyen TA; Torgerson DG; Kwok PY; Levin AM; Celedón JC; Forno E; Hakonarson H; Sleiman PM; Dahlin A; Tantisira KG; Weiss ST; Serebrisky D; Brigino-Buenaventura E; Farber HJ; Meade K; Lenoir MA; Avila PC; Sen S; Thyne SM; Rodriguez-Cintron W; Winkler CA; Moreno-Estrada A; Sandoval K; Rodriguez-Santana JR; Kumar R; Williams LK; Ahituv N; Ziv E; Seibold MA; Darnell RB; Zaitlen N; Hernandez RD; Burchard EG;
    Am J Respir Crit Care Med; 2018 Jun; 197(12):1552-1564. PubMed ID: 29509491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.
    Ortega VE; Meyers DA
    J Allergy Clin Immunol; 2014 Jan; 133(1):16-26. PubMed ID: 24369795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol.
    Choudhry S; Que LG; Yang Z; Liu L; Eng C; Kim SO; Kumar G; Thyne S; Chapela R; Rodriguez-Santana JR; Rodriguez-Cintron W; Avila PC; Stamler JS; Burchard EG
    Pharmacogenet Genomics; 2010 Jun; 20(6):351-8. PubMed ID: 20335826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.
    Kukreti R; Bhatnagar P; B-Rao C; Gupta S; Madan B; Das C; Guleria R; Athavale AU; Brahmachari SK; Ghosh B
    Pharmacogenomics; 2005 Jun; 6(4):399-410. PubMed ID: 16004558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.
    Israel E; Lasky-Su J; Markezich A; Damask A; Szefler SJ; Schuemann B; Klanderman B; Sylvia J; Kazani S; Wu R; Martinez F; Boushey HA; Chinchilli VM; Mauger D; Weiss ST; Tantisira KG;
    Am J Respir Crit Care Med; 2015 Mar; 191(5):530-7. PubMed ID: 25562107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease.
    Kim WJ; Oh YM; Sung J; Kim TH; Huh JW; Jung H; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Kwon SY; Lee SD
    Lung; 2008; 186(6):381-6. PubMed ID: 18758858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between polymorphisms in the 5' leader cistron, positions 16 and 27 of the adrenergic β2 receptor gene and asthma in a Han population from southwest China.
    Fu WP; Zhao ZH; Zhong L; Sun C; Fang LZ; Liu L; Zhang JQ; Wang L; Shu JK; Wang XM; Dai LM
    Respirology; 2011 Nov; 16(8):1221-7. PubMed ID: 21801278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Pharmacogenetic Predictive Test in asthma: proof of concept.
    Wu AC; Himes BE; Lasky-Su J; Litonjua A; Li L; Lange C; Lima J; Irvin CG; Weiss ST
    Pharmacogenet Genomics; 2010 Feb; 20(2):86-93. PubMed ID: 20032818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress and Bronchodilator Response in Children with Asthma.
    Brehm JM; Ramratnam SK; Tse SM; Croteau-Chonka DC; Pino-Yanes M; Rosas-Salazar C; Litonjua AA; Raby BA; Boutaoui N; Han YY; Chen W; Forno E; Marsland AL; Nugent NR; Eng C; Colón-Semidey A; Alvarez M; Acosta-Pérez E; Spear ML; Martinez FD; Avila L; Weiss ST; Soto-Quiros M; Ober C; Nicolae DL; Barnes KC; Lemanske RF; Strunk RC; Liu A; London SJ; Gilliland F; Sleiman P; March M; Hakonarson H; Duan QL; Kolls JK; Fritz GK; Hu D; Fani N; Stevens JS; Almli LM; Burchard EG; Shin J; McQuaid EL; Ressler K; Canino G; Celedón JC
    Am J Respir Crit Care Med; 2015 Jul; 192(1):47-56. PubMed ID: 25918834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
    Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
    Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
    Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
    Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.